Dipentum
- Product NDC
- 0037-6860
- 11-digit product format
- 000376860
- Labeler code
- 0037
- Product ID
- 0037-6860_9a4c3abc-74c9-4a2c-a8e3-fc0100d873d9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- olsalazine sodium
- Dosage form
- CAPSULE, GELATIN COATED
- Route
- ORAL
- Labeler
- Viatris Specialty LLC
- Application
- NDA019715
- Marketing category
- NDA
- Marketing start
- 2015-05-15
- Substance
- OLSALAZINE SODIUM
- Active strength
- 250 mg/1
- Pharmacologic classes
- Aminosalicylate [EPC], Aminosalicylic Acids [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Dipentum
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| OLSALAZINE SODIUM | 250 mg/1 |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | Y7JEW0XG7I |
| Rxcui | 905162, 905164 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6caced09-10d9-0a78-cc7d-35b444e1642b | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0037-6860-10 | Dipentum | 100 in 1 BOTTLE, PLASTIC | CAPSULE, GELATIN COATED | 100 | 15 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0037-6860-10 | EA - Each | 0037-6860 | 15c44237-9463-40ed-af62-9799cdc80f77 | 1 | 2015-06-09 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| OLSALAZINE SODIUM | ACTIVE INGREDIENT | Y7JEW0XG7I | DIPENTUM (OLSALAZINE SODIUM) CAPSULE, GELATIN COATED [MEDA PHARMACEUTICALS] | 1 | |
| OLSALAZINE | ACTIVE MOIETY | ULS5I8J03O | DIPENTUM (OLSALAZINE SODIUM) CAPSULE, GELATIN COATED [MEDA PHARMACEUTICALS] | 1 | |
| CARAMEL | INACTIVE INGREDIENT | T9D99G2B1R | DIPENTUM (OLSALAZINE SODIUM) CAPSULE, GELATIN COATED [MEDA PHARMACEUTICALS] | 1 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | DIPENTUM (OLSALAZINE SODIUM) CAPSULE, GELATIN COATED [MEDA PHARMACEUTICALS] | 1 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | DIPENTUM (OLSALAZINE SODIUM) CAPSULE, GELATIN COATED [MEDA PHARMACEUTICALS] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | DIPENTUM (OLSALAZINE SODIUM) CAPSULE, GELATIN COATED [MEDA PHARMACEUTICALS] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | DIPENTUM (OLSALAZINE SODIUM) CAPSULE, GELATIN COATED [MEDA PHARMACEUTICALS] | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 905164 | Dipentum 250 MG Oral Capsule | PSN | 8512d0c6-db4e-4673-b3b4-28975c18413f | 15 |
| 905162 | olsalazine sodium 250 MG Oral Capsule | PSN | 8512d0c6-db4e-4673-b3b4-28975c18413f | 15 |
| 905164 | olsalazine sodium 250 MG Oral Capsule [Dipentum] | SBD | 8512d0c6-db4e-4673-b3b4-28975c18413f | 15 |
| 905162 | olsalazine sodium 250 MG Oral Capsule | SCD | 8512d0c6-db4e-4673-b3b4-28975c18413f | 15 |
| 905164 | Dipentum 250 MG Oral Capsule | SY | 8512d0c6-db4e-4673-b3b4-28975c18413f | 15 |
| 905164 | Dipentum 250 MG Oral Capsule | PSN | 9dd522a3-587e-44ab-9de3-a0fd079f2ffb | 3 |
| 905162 | olsalazine sodium 250 MG Oral Capsule | PSN | 9dd522a3-587e-44ab-9de3-a0fd079f2ffb | 3 |
| 905164 | olsalazine sodium 250 MG Oral Capsule [Dipentum] | SBD | 9dd522a3-587e-44ab-9de3-a0fd079f2ffb | 3 |
| 905162 | olsalazine sodium 250 MG Oral Capsule | SCD | 9dd522a3-587e-44ab-9de3-a0fd079f2ffb | 3 |
| 905164 | Dipentum 250 MG Oral Capsule | SY | 9dd522a3-587e-44ab-9de3-a0fd079f2ffb | 3 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 0037-6860-10 | 00037686010 | 100 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (0037-6860-10) | 2015-05-15 | 0000-00-00 | No | No | Current |